(Q48009432)

7 February 2018

title

Persistently increased serum soluble interleukin-2 receptors in continuously ill patients with schizophrenia. (English)

1 reference

7 February 2018

0 references

Catherine Bresee

1

1 reference

7 February 2018

Mark H Rapaport

series ordinal

2

1 reference

7 February 2018

publication date

15 April 2009

1 reference

7 February 2018

The International Journal of Neuropsychopharmacology

published in

1 reference

7 February 2018

volume

12

1 reference

7 February 2018

issue

6

1 reference

7 February 2018

page(s)

861-865

1 reference

7 February 2018

The positive and negative syndrome scale (PANSS) for schizophrenia

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000315

7 January 2021

Increased serum levels of inflammatory markers in chronic institutionalized patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000315

7 January 2021

Serum levels of soluble IL-2 receptor alpha, IL-6 and IL-1 receptor antagonist in schizophrenia before and during neuroleptic administration

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000315

7 January 2021

Lower serum cytokine levels in smokers than nonsmokers with chronic schizophrenia on long-term treatment with antipsychotics

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000315

7 January 2021

The soluble interleukin-2 receptor: biology, function, and clinical application

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000315

7 January 2021

Neuroleptic treatment increases soluble IL-2 receptors and decreases soluble IL-6 receptors in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000315

7 January 2021

Serum-soluble interleukin-2 receptors in neuroleptic-naive schizophrenic subjects and in medicated schizophrenic subjects with and without tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000315

7 January 2021

Elevated levels of soluble interleukin 2 receptors in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000315

7 January 2021

An association between increased serum-soluble interleukin-2 receptors and a disturbance in muscle force in schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000315

7 January 2021

Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000315

7 January 2021

The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000315

7 January 2021

Increased serum soluble interleukin-2 receptors in schizophrenic monozygotic twins

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000315

7 January 2021

10.1017/S1461145709000315

Identifiers

DOI

1 reference

7 February 2018

PubMed ID

19366488

1 reference

7 February 2018